There is a shortage of life saving cancer drugs that could save lives that are not available because those drugs are now less expensive and are there’s no profit motive for companies to produce these generic drugs that sell for very little cost. These drugs are not being produced because they don’t produce a large profit to manufacturer who can profit better when that drug is at its greatest demand. In the meantime children with cancer are now facing a Methotrexate shortage in a few short weeks. Methotrexate is the primary treatment drug for acute lymphoblastic leukemia. In November, one of the four U.S. manufacturers of Methotrexate was shut down because of quality concerns, this move emptied pharmacy shelves, the FDA say they have given the green light for companies that produce Methotrexate to ramp up production. There are still 200 hundred shortages of life saving drugs the FDA needs to look at a long term solution so we never have this problem again.
